Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathwayAnnalisa Lonetti, Francesca Chiarini|Journal of Hematology & Oncology|2016Cited by 62
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitorsAnnalisa Lonetti, Alberto M. Martelli|Oncotarget|2015Cited by 38